Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis
Open Access
- 1 May 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (5), 1773-1777
- https://doi.org/10.1128/aac.48.5.1773-1777.2004
Abstract
Candida glabrata can become resistant to fluconazole, causing persistent colonization and invasive infection during prolonged exposure to the drug. To determine the mechanism of resistance in this setting, weekly oropharyngeal cultures for C. glabrata were obtained over a 2-year period from hematopoietic stem cell transplant recipients who were receiving fluconazole prophylaxis. In 20 patients from whom at least two isolates of the same karyotype were obtained more than two weeks apart, fluconazole MICs doubled every 31 days on average. The mechanism of fluconazole resistance in isolates from the 14 of the 20 patients studied in whom MICs changed at least fourfold was studied. Cellular resistance was accompanied by increased drug efflux as measured by decreased accumulation of fluconazole and rhodamine 6G and increased abundance of transcripts from two drug transporters, CgCDR1 and PDH1. The rapidity and regularity of the rising resistance indicated that C. glabrata is able to upregulate drug efflux without losing the ability to maintain colonization.Keywords
This publication has 24 references indexed in Scilit:
- Function of Candida glabrata ABC transporter gene, PDH1Yeast, 2003
- In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida sppAntimicrobial Agents and Chemotherapy, 2002
- Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequencesThe Lancet Infectious Diseases, 2002
- Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicansAntimicrobial Agents and Chemotherapy, 2001
- Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic FluconazoleThe Journal of Infectious Diseases, 2000
- The ATP Binding Cassette Transporter Gene CgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal AgentsAntimicrobial Agents and Chemotherapy, 1999
- Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis [published erratum appears in J Antimicrob Chemother 1998 Sep;42(3):413]Journal of Antimicrobial Chemotherapy, 1998
- Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transportersAntimicrobial Agents and Chemotherapy, 1995
- Fluconazole resistance due to energy-dependent drug efflux in Candida glabrataAntimicrobial Agents and Chemotherapy, 1995
- Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrataJournal of General Microbiology, 1991